Ser705

Javascript is not enabled on this browser. This site will not work properly without Javascript.

Home > Phosphorylation Site Page: > Ser705 - ERK3 (human)

Site Information
tPSAMkssPQIPHQT SwissProt Entrez-Gene
Blast this site against: NCBI SwissProt PDB
Site Group ID: 13830501

In vivo Characterization
Methods used to characterize site in vivo:	electrophoretic mobility shift ( 1 ) , mass spectrometry ( 1 ) , mass spectrometry (in vitro) ( 1 ) , mutation of modification site ( 1 )
Relevant cell line - cell type - tissue:	HeLa (cervical) ( 1 )

Upstream Regulation
Kinases, in vitro:	CDK1 (human) ( 1 )
Treatments:	nocodazole ( 1 )

Downstream Regulation
Effects of modification on ERK3:	protein stabilization ( 1 )

References
1	Tanguay PL, Rodier G, Meloche S (2010) C-terminal domain phosphorylation of ERK3 controlled by Cdk1 and Cdc14 regulates its stability in mitosis. Biochem J 428, 103-11 20236090 Curated Info

Developed with grants from

and literature mining with Linguamatics

PhosphoSite, created by Cell Signaling Technology is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License.